Noua Zeelandă aprobă MDMA pentru tratarea stresului post-traumatic. Cine poate primi tratamentul? • Newsweek România

New Zealand has become the second country to approve MDMA for treating PTSD, following Australia. Medsafe has authorized two psychiatrists to prescribe MDMA for severe cases of PTSD, emphasizing that treatment will occur in controlled clinical settings. Patients must be at least 18 years old and will receive MDMA alongside psychotherapy under professional supervision. The vice-premier highlighted the potential effectiveness of MDMA in addressing PTSD, a condition that can arise from traumatic events. A recent study suggested that MDMA may help mitigate trauma effects in festival attendees during a violent incident.